학술논문

Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes
Document Type
article
Source
Diabetologia. 56(2)
Subject
Diabetes
Human Genome
Nutrition
Genetics
Aetiology
2.1 Biological and endogenous factors
Metabolic and endocrine
Diabetes Mellitus
Type 2
Exome
Gene Frequency
Genotype
High-Throughput Nucleotide Sequencing
Humans
Hypertension
Polymorphism
Genetic
Polymorphism
Single Nucleotide
Exome sequencing
Genetic epidemiology
Lipids
Next-generation sequencing
Obesity
Type 2 diabetes
D.E.S.I.R. Study Group
DIAGRAM Consortium
Clinical Sciences
Paediatrics and Reproductive Medicine
Public Health and Health Services
Endocrinology & Metabolism
Language
Abstract
Aims/hypothesisHuman complex metabolic traits are in part regulated by genetic determinants. Here we applied exome sequencing to identify novel associations of coding polymorphisms at minor allele frequencies (MAFs) >1% with common metabolic phenotypes.MethodsThe study comprised three stages. We performed medium-depth (8×) whole exome sequencing in 1,000 cases with type 2 diabetes, BMI >27.5 kg/m(2) and hypertension and in 1,000 controls (stage 1). We selected 16,192 polymorphisms nominally associated (p 1%. In stage 2 we identified 51 potential associations with one or more of eight metabolic phenotypes covered by 45 unique polymorphisms. In meta-analyses of stage 2 and stage 3 results, we demonstrated robust associations for coding polymorphisms in CD300LG (fasting HDL-cholesterol: MAF 3.5%, p = 8.5 × 10(-14)), COBLL1 (type 2 diabetes: MAF 12.5%, OR 0.88, p = 1.2 × 10(-11)) and MACF1 (type 2 diabetes: MAF 23.4%, OR 1.10, p = 8.2 × 10(-10)).Conclusions/interpretationWe applied exome sequencing as a basis for finding genetic determinants of metabolic traits and show the existence of low-frequency and common coding polymorphisms with impact on common metabolic traits. Based on our study, coding polymorphisms with MAF above 1% do not seem to have particularly high effect sizes on the measured metabolic traits.